MyChesCo on MSN

Medicus reports phase 2 results for SkinJect basal cell carcinoma study

PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) reported additional data from its Phase 2 SKNJCT-003 clinical study ...